Box Office: ‘Michael’ Starts Strong With $39.5 Million; Expected to Shatter Record for Best Music Biopic Opening

Lionsgate’s "Michael" opened with $39.5 million on Friday and is projected to reach $90 million to $100 million by Sunday, marking the best debut ever for a music biopic. The film carries a $155 million production budget, so the opening is strong but still leaves execution risk given the high cost base. Other box office titles were mixed, with "The Super Mario Galaxy Movie" and "Project Hail Mary" tracking to solid weekend totals.

Analysis

The opening strength is a clear near-term cash-flow positive for exhibitors, but the bigger winner is the studio slate economics across premium-format-heavy tentpoles. A breakout biopic with a high production budget improves the market’s willingness to fund eventized adult-skewing IP, which can lift financing terms for studios with deep catalogs and punish smaller distributors that cannot absorb marketing or rights overages. The second-order effect is on theater operators’ concession leverage: sustained attendance from an older audience can support higher per-cap spend and reduce dependence on franchise-only footfall.

The key risk is not demand at opening, but the path from headline gross to studio profit over the next 3-6 months. Expensive rights, re-edit costs, and likely back-end participation mean this can still be only modestly accretive unless domestic legs are unusually durable and overseas uptake improves. If weekend-to-weekday decay is steep, the market will quickly reclassify the result from “home run” to “good opening, mediocre return,” which matters for sentiment around greenlighting similarly expensive music biographies.

The competitive read-through is also mixed for other studios: a strong adult event film can cannibalize share of wallet from lower-conviction dramas and prestige releases, while leaving franchise titles largely untouched. The broader exhibition thesis improves if this film sustains turnout for 2-3 weeks, because it would imply that non-superhero counterprogramming still has pricing power. If not, the move is overdone and the box office headline becomes a one-week trading event rather than a durable demand signal.

Contrarian view: the market may be overstating the quality of the signal because opening weekend enthusiasm is likely amplified by nostalgia and controversy, both of which fade quickly. The real tell is the next two weekends and whether premium-format occupancy holds above the low-40% range; if it falls below that, the film’s economics remain fragile despite the strong start. In that case, the best trade is not on the studio itself, but on the exhibitors whose near-term comps benefit while the long-duration implication stays limited.

Key Decisions for Investors

• Long CNK or IMAX for 2-3 weeks into the release window: momentum in premium-format attendance should support near-term revenue per patron; take profit if second-weekend drop exceeds ~55%, which would signal the trend is not durable.
• Avoid chasing a long in Lionsgate-equivalent small-cap studio exposure; the budget/rights overhang means a strong opening does not automatically translate into equity upside unless the film sustains exceptionally strong legs over the next 30-60 days.
• Pair trade: long AMC / short a basket of lower-quality content financiers if you want to express a view that exhibitor foot traffic improves faster than studio margin quality; thesis breaks if weekday attendance normalizes sharply after opening week.
• Use call spreads on IMAX over the next 1-2 months to express asymmetric upside from event-film spillover without paying for full equity beta; risk is limited to a rapid fade in premium-screen demand.